Oncotarget

Corrections:

Correction: SNiPER: a novel hypermethylation biomarker panel for liquid biopsy based early breast cancer detection

PDF  |  How to cite

Oncotarget. 2020; 11:2958-2958. https://doi.org/10.18632/oncotarget.27685

Metrics: PDF 68 views  |   ?  

Jolein Mijnes1, Janina Tiedemann1, Julian Eschenbruch1, Janina Gasthaus1, Sarah Bringezu1, Dirk Bauerschlag3, Nicolai Maass3, Norbert Arnold3,6, Jörg Weimer3, Tobias Anzeneder4, Peter A. Fasching5, Matthias Rübner5, Benjamin Bruno7, Uwe Heindrichs7, Jennifer Freres7, Hanna Schulz1, Ralf-Dieter Hilgers8, Nadina Ortiz-Brüchle1, Sonja von Serenyi1, Ruth Knüchel1, Vera Kloten1,9,* and Edgar Dahl1,2,*

1 Molecular Oncology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany
2 RWTH centralized Biomaterial Bank (RWTH cBMB) at the Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany
3 Department of Gynecology and Obstetrics, University Medical Centre Schleswig-Holstein, Campus Kiel, Kiel, Germany
4 Patients' Tumor Bank of Hope (PATH-Biobank) Foundation, München, Germany
5 Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany
6 Institute of Clinical Molecular Biology, University Medical Centre Schleswig-Holstein, Campus Kiel, Christian-Albrechts- University, Kiel, Germany
7 Department of Gynecology and Obstetrics Luisenhospital, Aachen, Germany
8 Institute of Medical Statistics, University Hospital RWTH Aachen, Aachen, Germany
9 Current address: Bayer AG, Pharmaceuticals Division, Biomarker Research, Wuppertal, Germany
* Share equal senior authorship

Published: July 28, 2020

This article has been corrected: The Grant section information has been updated with the following logos:

Original article: Oncotarget. 2019; 10:6494–6508. DOI: https://doi.org/10.18632/oncotarget.27303.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 27685